Back to KPV
KPV Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for KPV.
Dosing & Reconstitution Guide
In rodent studies, KPV has been administered orally or topically at 1–5 mg/kg. No approved use exists for humans.
Standard / Gradual Approach
10mg VialstandardPhaseDoseVolume
Week 1200 mcg6 units (0.06 mL)
Week 2300 mcg9 units (0.09 mL)
Week 3400 mcg12 units (0.12 mL)
Weeks 4–8500 mcg15 units (0.15 mL)
Protocol Summary
Oral: Daily · Dose range 100–500 mcg with gradual titration
Subcutaneous (SQ): daily · Dose range 100–500 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
Oral
Typical dose: 250–500 mcg/day in capsule form. Can be taken long-term under supervision for chronic gut inflammation.
Subcutaneous (SQ)
200–400 mcg daily SubQ recommended for systemic anti-inflammatory effects. Use in 4–8 week cycles with evaluation.
Topical
Apply 2% KPV cream to affected skin areas twice daily. Safe for continuous use in inflammatory skin conditions.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3300 mcg/unit
Starting Dose
200 mcg (6 units (0.06 mL))
Maintenance Dose
500 mcg (15 units (0.15 mL))
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe